NHS England has recently launched a new programme of National Medicines Optimisation Opportunities for 2023/24. The guidance outlines 16 key areas of focus, including:
- addressing problematic polypharmacy
- improving respiratory outcomes while reducing the carbon emissions from inhalers
- recuing course length of antibiotic prescribing.
Integrated Care Boards (ICBs) are advised to select at least five to implement alongside their local priorities.
The OpenPrescribing team have created a Medicines Optimisation dashboard which provides data at practice, PCN, ICB and NHS England regional level. This will help inform local discussions about how to best select and address the opportunities set out by NHS England. You can read more about the dashboard and how to use it in the blog.